NEW YORK--(BUSINESS WIRE)--NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for August 20111. Trading volumes across all venues were significantly higher, both year-over-year and sequentially due to heightened market volatility in the U.S. and Europe resulting in new monthly trading records in U.S. equity options and European cash. Global derivatives average daily volume (“ADV”) of 10.4 million contracts in August 2011 increased 64.6% versus the prior year driven by a 91.3% increase in U.S. options ADV to a record 5.8 million contracts and a 36.5% increase in European derivatives. Cash equities ADV in August 2011 was strong, with European cash ADV increasing 70.3% to a record 2.2 million trades per day and U.S. cash trading ADV increasing 38.9% from August 2010 levels.
Highlights
- NYSE Euronext global derivatives ADV in August 2011 of 10.4 million contracts increased 64.6% compared to August 2010 and increased 30.5% from July 2011 levels.
- NYSE Euronext European derivatives products ADV in August 2011 of 4.5 million contracts increased 36.5% compared to August 2010 and increased 21.1% from July 2011 levels. Excluding Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives products ADV increased 53.1% compared to August 2010 and increased 35.4% from July 2011.
- NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) record ADV of 5.8 million contracts in August 2011 increased 91.3% compared to August 2010 levels and increased 38.9% from July 2011. NYSE Euronext’s U.S. options exchanges accounted for 26.4% of total U.S. consolidated equity options trading in August 2011, up from 25.2% in August 2010 and up from 25.8% recorded in July 2011.
- NYSE Liffe U.S. ADV of approximately 137,100 contracts increased from 9,600 contracts in August 2010 and 101,300 contracts in July 2011. Total exchange open interest is now over 900,000 contracts.
- NYSE Euronext European cash products record ADV of 2.2 million transactions in August 2011 increased 70.3% compared to August 2010 and increased 32.7% from July 2011 levels.
- NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE Amex) handled ADV of 3.2 billion shares in August 2011 increased 38.9% compared to August 2010 and increased 60.0% compared to July 2011. NYSE Euronext’s Tape A matched market share in August 2011 was 36.2%, down from 38.1% in August 2010, but up from 34.3% in July 2011.
- There were a total of 23 trading days in Europe and the U.S. in August 2011 compared to 22 trading days in Europe and the U.S. in August 2010.
Derivatives Trading
European Derivatives
- NYSE Euronext European derivatives products ADV in August 2011 was 4.5 million futures and options contracts, an increase of 36.5% from August 2010 and an increase of 21.1% from July 2011.
- The 4.5 million in European derivatives futures and options contracts ADV in August 2011 consisted of 4.0 million contracts executed through our full-service LIFFE CONNECT trading platform and 0.5 million contracts, or 11.7%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products. Excluding Bclear, European derivatives products ADV increased 53.1% compared to August 2010 and increased 35.4% from July 2011.
- Year-to-date, European derivatives products ADV of 4.7 million contracts was 8.6% below prior year levels. The 4.7 million in futures and options contracts ADV year-to-date consisted of 3.5 million contracts executed through LIFFE CONNECT trading platform and 1.2 million contracts, or 26.1%, executed through Bclear.
- Total fixed income products ADV of 2.6 million contracts in August 2011 increased 57.4% from August 2010 and increased 37.3% from July 2011. Year-to-date, total fixed income products ADV of 2.4 million contracts was 3.4% below prior year levels.
- Total equity products (including Bclear) ADV of 1.8 million contracts in August 2011 increased 17.5% compared to August 2010 and increased 5.2% from July 2011. The 1.8 million contracts in equity products ADV consisted of 1.0 million contracts in individual equity products ADV and 0.8 million contracts in equity index products ADV. The 1.1 million contracts in individual equity products ADV consisted of 0.4 million in futures contracts, which represented a 36.8% decrease compared to August 2010 and 0.7 million in options contracts, which represented a 41.6% increase compared to August 2010. The average net rate per contract for individual equity futures contracts is significantly lower than other products traded on NYSE Liffe. Year-to-date, total equity products ADV of 2.3 million contracts was 14.5% below prior year levels.
- Total commodities products ADV of 67,000 contracts in August 2011 decreased 18.4% compared to August 2010 and decreased 13.6% compared to July 2011. Year-to-date, total commodities product ADV of 83,000 contracts was 34.5% above prior year levels.
U.S. Derivatives
- NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) record ADV of 5.8 million contracts in August 2011 increased 91.3% compared to August 2010 and increased 38.9% compared to July 2011. Year-to-date, U.S. equity options ADV of 4.4 million contracts was 20.3% above prior year levels.
- Total U.S. consolidated equity options ADV increased 83.1% to 21.8 million contracts in August 2011 compared to August 2010 and increased 36.1% compared to July 2011. Year-to-date, U.S. consolidated equity options ADV of 17.2 million contracts was 21.5% above prior year levels.
- NYSE Euronext’s U.S. options exchanges accounted for 26.4% of the total U.S. consolidated equity options trading in August 2011, up from 25.2% in August 2010 and up from 25.8% in July 2011.
- NYSE Liffe U.S. ADV of approximately 137,100 contracts increased from 9,600 contracts in August 2010 and 101,300 contracts in July 2011. Total exchange open interest is now over 900,000 contracts. Year-to-date, U.S. futures and futures options ADV of 73,300 contracts was 322.7% above prior year levels.
Cash Trading
European Cash
- NYSE Euronext European cash products record ADV of 2.2 million transactions in August 2011 increased 70.3% compared to August 2010 and increased 32.7% compared to July 2011.
- Year-to-date, European cash products ADV of 1.7 million transactions was 16.2% above prior year levels.
U.S. Cash
- NYSE Euronext U.S. cash products handled ADV in August 2011 increased 38.9% to 3.2 billion shares compared to August 2010 and increased 60.0% from July 2011.
- Year-to-date, U.S. cash products handled ADV was 2.3 billion shares, down 17.0% from prior year levels.
- NYSE Euronext’s Tape A matched market share in August 2011 was 36.2%, down from 38.1% in August 2010, but up from 34.3% in July 2011.
Exchange Traded Funds
- NYSE Euronext U.S. matched exchange-traded funds ADV (included in volumes for Tape B and Tape C) of 517 million shares in August 2011 increased 71.5% compared to August 2010 and increased 86.8% compared to July 2011.
- Year-to-date, NYSE Euronext U.S. matched exchange-traded funds ADV of 312 million shares was 12.9% below prior year levels.
Please click here for the Monthly Transaction Activity Data Table.
About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-third of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the Fortune 500. For more information, please visit: http://www.nyx.com.
Safe Harbour Statement
In connection with the proposed business combination transaction between NYSE Euronext and Deutsche Boerse AG, Alpha Beta Netherlands Holding N.V. (“Holding”), a newly formed holding company, filed, and the SEC declared effective on May 3, 2011, a Registration Statement on Form F-4 with the U.S. Securities and Exchange Commission (“SEC”) that includes (1) a proxy statement of NYSE Euronext that also constitutes a prospectus for Holding used in connection with NYSE Euronext special meeting of stockholders held on July 7, 2011 and (2) an offering prospectus used in connection with Holding’s offer to acquire Deutsche Boerse AG shares held by U.S. holders. Holding has also filed an offer document with the German Federal Financial Supervisory Authority (Bundesanstalt fuer Finanzdienstleistungsaufsicht) (“BaFin”), which was approved by the BaFin for publication pursuant to the German Takeover Act (Wertpapiererwerbs-und Übernahmegesetz), and was published on May 4, 2011.
Investors and security holders are urged to read the definitive proxy statement/prospectus, the offering prospectus, the offer document, as amended, and published additional accompanying information in connection with the exchange offer regarding the proposed business combination transaction because they contain important information. You may obtain a free copy of the definitive proxy statement/prospectus, the offering prospectus and other related documents filed by NYSE Euronext and Holding with the SEC on the SEC’s website at www.sec.gov. The definitive proxy statement/prospectus and other documents relating thereto may also be obtained for free by accessing NYSE Euronext’s website at www.nyse.com. The offer document, as amended, and published additional accompanying information in connection with the exchange offer are available at Holding’s website at www.global-exchange-operator.com.
This document is neither an offer to purchase nor a solicitation of an offer to sell shares of Holding, Deutsche Boerse AG or NYSE Euronext. The final terms and further provisions regarding the public offer are disclosed in the offer document that has been approved by the BaFin and in documents that have been filed with the SEC.
No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended, and applicable European regulations. The exchange offer and the exchange offer document as amended, shall not constitute an issuance, publication or public advertising of an offer pursuant to laws and regulations of jurisdictions other than those of Germany, United Kingdom of Great Britain and Northern Ireland and the United States of America. The relevant final terms of the proposed business combination transaction will be disclosed in the information documents reviewed by the competent European market authorities.
Subject to certain exceptions, in particular with respect to qualified institutional investors (tekikaku kikan toshika) as defined in Article 2 para. 3 (i) of the Financial Instruments and Exchange Act of Japan (Law No. 25 of 1948, as amended), the exchange offer will not be made directly or indirectly in or into Japan, or by use of the mails or by any means or instrumentality (including without limitation, facsimile transmission, telephone and the internet) of interstate or foreign commerce or any facility of a national securities exchange of Japan. Accordingly, copies of this announcement or any accompanying documents may not be, directly or indirectly, mailed or otherwise distributed, forwarded or transmitted in, into or from Japan.
The shares of Holding have not been, and will not be, registered under the applicable securities laws of Japan. Accordingly, subject to certain exceptions, in particular with respect to qualified institutional investors (tekikaku kikan toshika) as defined in Article 2 para. 3 (i) of the Financial Instruments and Exchange Act of Japan (Law No. 25 of 1948, as amended), the shares of Holding may not be offered or sold within Japan, or to or for the account or benefit of any person in Japan.
1 All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.
|
NYSE Euronext |
|||||||||||||||||||||||||||||||||
|
Monthly Volume Summary |
|||||||||||||||||||||||||||||||||
| Average Daily Volume | Total Volume | Average Daily Volume | Total Volume | ||||||||||||||||||||||||||||||
| (Unaudited; contracts in thousands) | Aug-11 | Aug-10 | % Chg | Aug-11 | Aug-10 | % Chg | YTD 2011 | % Chg vs. YTD 2010 | YTD 2011 | % Chg vs. YTD 2010 | |||||||||||||||||||||||
| Number of Trading Days - European Markets | 23 | 22 | 23 | 22 | 171 | 171 | |||||||||||||||||||||||||||
| Number of Trading Days - U.S. Markets | 23 | 22 | 23 | 22 | 168 | 168 | |||||||||||||||||||||||||||
| European Derivatives Products | 4,493 | 3,291 | 36.5 | % | 103,332 | 72,409 | 42.7 | % | 4,745 | -8.6 | % | 811,316 | -8.1 | % | |||||||||||||||||||
| of which Bclear | 527 | 701 | -24.8 | % | 12,120 | 15,418 | -21.4 | % | 1,238 | -20.4 | % | 211,777 | -19.9 | % | |||||||||||||||||||
| Total Fixed Income Products | 2,583 | 1,641 | 57.4 | % | 59,398 | 36,099 | 64.5 | % | 2,380 | -3.4 | % | 406,921 | -2.8 | % | |||||||||||||||||||
| Short Term Interest Rate Products | 2,410 | 1,520 | 58.6 | % | 55,437 | 33,439 | 65.8 | % | 2,240 | -4.6 | % | 383,002 | -4.0 | % | |||||||||||||||||||
|
Medium and Long Term Interest Rate Products 1 |
172 | 121 | 42.4 | % | 3,961 | 2,660 | 48.9 | % | 140 | 20.8 | % | 23,918 | 21.5 | % | |||||||||||||||||||
|
Total Equity Products 2 |
1,843 | 1,568 | 17.5 | % | 42,386 | 34,496 | 22.9 | % | 2,282 | -14.5 | % | 390,274 | -14.0 | % | |||||||||||||||||||
| Individual Equity Products | 1,066 | 1,070 | -0.4 | % | 24,529 | 23,549 | 4.2 | % | 1,699 | -16.8 | % | 290,593 | -16.3 | % | |||||||||||||||||||
| Futures | 362 | 573 | -36.8 | % | 8,325 | 12,605 | -34.0 | % | 1,075 | -19.6 | % | 183,903 | -19.2 | % | |||||||||||||||||||
| Options | 705 | 497 | 41.6 | % | 16,204 | 10,944 | 48.1 | % | 624 | -11.3 | % | 106,691 | -10.7 | % | |||||||||||||||||||
| Equity Index Products | 776 | 498 | 56.0 | % | 17,857 | 10,946 | 63.1 | % | 583 | -7.0 | % | 99,681 | -6.4 | % | |||||||||||||||||||
| of which Bclear | 527 | 701 | -24.8 | % | 12,120 | 15,418 | -21.4 | % | 1,238 | -20.4 | % | 211,777 | -19.9 | % | |||||||||||||||||||
| Individual Equity Products | 424 | 631 | -32.9 | % | 9,751 | 13,890 | -29.8 | % | 1,160 | -20.3 | % | 198,445 | -19.9 | % | |||||||||||||||||||
| Futures | 319 | 555 | -42.6 | % | 7,333 | 12,213 | -40.0 | % | 1,056 | -20.8 | % | 180,613 | -20.3 | % | |||||||||||||||||||
| Options | 105 | 76 | 37.9 | % | 2,418 | 1,677 | 44.2 | % | 104 | -15.5 | % | 17,832 | -15.0 | % | |||||||||||||||||||
| Equity Index Products | 103 | 69 | 48.3 | % | 2,369 | 1,528 | 55.1 | % | 78 | -20.7 | % | 13,332 | -20.3 | % | |||||||||||||||||||
| Commodity Products | 67 | 82 | -18.4 | % | 1,548 | 1,813 | -14.6 | % | 83 | 34.5 | % | 14,122 | 35.3 | % | |||||||||||||||||||
| U.S. Derivatives Products | |||||||||||||||||||||||||||||||||
|
Equity Options 3 |
|||||||||||||||||||||||||||||||||
| NYSE Euronext Options Contracts | 5,751 | 3,006 | 91.3 | % | 132,265 | 66,135 | 100.0 | % | 4,427 | 20.3 | % | 743,818 | 21.1 | % | |||||||||||||||||||
| Total Consolidated Options Contracts | 21,824 | 11,920 | 83.1 | % | 501,948 | 262,233 | 91.4 | % | 17,193 | 21.5 | % | 2,888,506 | 22.3 | % | |||||||||||||||||||
| NYSE Group Share of Total | 26.4 | % | 25.2 | % | 26.4 | % | 25.2 | % | 25.8 | % | -0.2 | % | 25.8 | % | -0.2 | % | |||||||||||||||||
| NYSE Liffe U.S. | |||||||||||||||||||||||||||||||||
| Futures and Futures Options Volume* | 137.1 | 9.6 | 1335.1 | % | 3,154 | 210 | 1400.3 | % | 73.3 | 322.7 | % | 12,605.4 | 335.4 | % | |||||||||||||||||||
| European Cash Products (trades in thousands) | 2,176 | 1,278 | 70.3 | % | 50,056 | 28,110 | 78.1 | % | 1,736 | 16.2 | % | 296,865 | 16.9 | % | |||||||||||||||||||
| Equities | 2,090 | 1,224 | 70.7 | % | 48,060 | 26,932 | 78.4 | % | 1,669 | 16.4 | % | 285,400 | 17.0 | % | |||||||||||||||||||
| Exchange-Traded Funds | 29 | 15 | 91.3 | % | 676 | 338 | 100.0 | % | 20 | 10.8 | % | 3,413 | 11.4 | % | |||||||||||||||||||
| Structured Products | 53 | 34 | 57.1 | % | 1,219 | 742 | 64.2 | % | 42 | 17.6 | % | 7,186 | 18.3 | % | |||||||||||||||||||
| Bonds | 4 | 4 | -0.5 | % | 101 | 97 | 4.0 | % | 5 | -12.5 | % | 866 | -12.0 | % | |||||||||||||||||||
| U.S. Cash Products (shares in millions) 5 | 3,189 | 2,296 | 38.9 | % | 73,347 | 50,516 | 45.2 | % | 2,304 | -17.0 | % | 387,141 | -16.5 | % | |||||||||||||||||||
| NYSE Listed (Tape A) Issues 4 | |||||||||||||||||||||||||||||||||
| Handled Volume 5 | 2,216 | 1,643 | 34.9 | % | 50,975 | 36,151 | 41.0 | % | 1,631 | -19.1 | % | 274,084 | -18.6 | % | |||||||||||||||||||
| Matched Volume 6 | 2,107 | 1,554 | 35.5 | % | 48,450 | 34,190 | 41.7 | % | 1,546 | -18.0 | % | 259,680 | -17.5 | % | |||||||||||||||||||
| Total NYSE Listed Consolidated Volume | 5,817 | 4,079 | 42.6 | % | 133,794 | 89,741 | 49.1 | % | 4,413 | -14.8 | % | 741,362 | -14.3 | % | |||||||||||||||||||
| Share of Total Consolidated Volume | |||||||||||||||||||||||||||||||||
| Handled Volume 5 | 38.1 | % | 40.3 | % | -2.2 | % | 38.1 | % | 40.3 | % | -2.2 | % | 37.0 | % | -1.9 | % | 37.0 | % | -1.9 | % | |||||||||||||
| Matched Volume 6 | 36.2 | % | 38.1 | % | -1.9 | % | 36.2 | % | 38.1 | % | -1.9 | % | 35.0 | % | -1.4 | % | 35.0 | % | -1.4 | % | |||||||||||||
| NYSE Arca & Amex (Tape B) Listed Issues | |||||||||||||||||||||||||||||||||
| Handled Volume 5 | 585 | 340 | 72.2 | % | 13,464 | 7,479 | 80.0 | % | 372 | -10.0 | % | 62,556 | -9.5 | % | |||||||||||||||||||
| Matched Volume 6 | 528 | 310 | 70.3 | % | 12,142 | 6,819 | 78.1 | % | 335 | -9.6 | % | 56,266 | -9.1 | % | |||||||||||||||||||
| Total NYSE Arca & Amex Listed Consolidated Volume | 2,248 | 1,238 | 81.6 | % | 51,705 | 27,234 | 89.9 | % | 1,441 | -8.4 | % | 242,033 | -7.8 | % | |||||||||||||||||||
| Share of Total Consolidated Volume | |||||||||||||||||||||||||||||||||
|
Handled Volume 5 |
26.0 | % | 27.5 | % | -1.5 | % | 26.0 | % | 27.5 | % | -1.5 | % | 25.8 | % | -0.5 | % | 25.8 | % | -0.5 | % | |||||||||||||
|
Matched Volume 6 |
23.5 | % | 25.0 | % | -1.5 | % | 23.5 | % | 25.0 | % | -1.5 | % | 23.2 | % | -0.3 | % | 23.2 | % | -0.3 | % | |||||||||||||
| Nasdaq Listed (Tape C) Issues | |||||||||||||||||||||||||||||||||
| Handled Volume 5 | 387 | 313 | 23.7 | % | 8,908 | 6,886 | 29.4 | % | 301 | -12.9 | % | 50,500 | -12.4 | % | |||||||||||||||||||
| Matched Volume 6 | 342 | 272 | 25.8 | % | 7,877 | 5,988 | 31.5 | % | 258 | -10.9 | % | 43,287 | -10.4 | % | |||||||||||||||||||
| Total Nasdaq Listed Consolidated Volume | 2,522 | 1,936 | 30.2 | % | 57,996 | 42,595 | 36.2 | % | 2,076 | -10.9 | % | 348,717 | -10.3 | % | |||||||||||||||||||
| Share of Total Consolidated Volume | |||||||||||||||||||||||||||||||||
| Handled Volume 5 | 15.4 | % | 16.2 | % | -0.8 | % | 15.4 | % | 16.2 | % | -0.8 | % | 14.5 | % | -0.3 | % | 14.5 | % | -0.3 | % | |||||||||||||
| Matched Volume 6 | 13.6 | % | 14.1 | % | -0.5 | % | 13.6 | % | 14.1 | % | -0.5 | % | 12.4 | % | 0.0 | % | 12.4 | % | 0.0 | % | |||||||||||||
| Exchange-Traded Funds 5,7 | |||||||||||||||||||||||||||||||||
| Handled Volume 5 | 574 | 331 | 73.5 | % | 13,200 | 7,278 | 81.4 | % | 347 | -13.0 | % | 58,353 | -12.5 | % | |||||||||||||||||||
| Matched Volume 6 | 517 | 302 | 71.5 | % | 11,900 | 6,636 | 79.3 | % | 312 | -12.9 | % | 52,449 | -12.4 | % | |||||||||||||||||||
| Total ETF Consolidated Volume | 2,250 | 1,228 | 83.3 | % | 51,758 | 27,011 | 91.6 | % | 1,368 | -12.1 | % | 229,836 | -11.6 | % | |||||||||||||||||||
| Share of Total Consolidated Volume | |||||||||||||||||||||||||||||||||
| Handled Volume 5 | 25.5 | % | 26.9 | % | -1.4 | % | 25.5 | % | 26.9 | % | -1.4 | % | 25.4 | % | -0.3 | % | 25.4 | % | -0.3 | % | |||||||||||||
| Matched Volume 6 | 23.0 | % | 24.6 | % | -1.6 | % | 23.0 | % | 24.6 | % | -1.6 | % | 22.8 | % | -0.2 | % | 22.8 | % | -0.2 | % | |||||||||||||
| 1 | Data includes currency products. | |
|
2 |
Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives. | |
| 3 | Includes trading in U.S. equity options contracts, not equity-index options. | |
| 4 | Includes all volume executed in NYSE Group crossing sessions. | |
| 5 | Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots. | |
| 6 | Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges. | |
| 7 | Data included in previously identified categories. | |
| * | ADVs calculated with the appropriate number of NYSE Liffe U.S. trading. | |
| Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities. | ||
| All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells. | ||